ஆண்டு ஆபெந்ஹைமர் சுகாதாரம் மாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆண்டு ஆபெந்ஹைமர் சுகாதாரம் மாநாடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆண்டு ஆபெந்ஹைமர் சுகாதாரம் மாநாடு Today - Breaking & Trending Today

Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business .
Shattuck Labs, Inc.March 15, 2021 GMT
– Initial dose-escalation data from Phase 1 clinical trial for lead wholly owned CD47 checkpoint inhibitor, SL-172154 (SIRPα-Fc-CD40L), expected in the second half of 2021 –
– Dose-escalation data from Phase 1 clinical trial for lead partnered PD-1 checkpoint inhibitor, SL-279252 (PD1-Fc-OX40L), expected in the second half of 2021 –
AUSTIN, TX and DURHAM, NC, March 15, 2021 (GLOBE NEWSWIRE) Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK ), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today reported financial results for the fourth quarter and full year ended December 31, 2 ....

United States , North Carolina , Stephanie Ascher , Conor Richardson , Taylor Schreiber , Preclinical Development , Stern Investor Relations Inc , Society For Immunotherapy Of Cancer , Takeda Pharmaceuticals , Exchange Commission , Development Rd Expenses , American Association For Cancer Research , Shattuck Labs Inc , Truist Securities Life Sciences Summit , Agonist Redirected Checkpoint , Chief Executive Officer , Investigational New Drug , Gamma Deltat Cell Engager , Business Highlights , Ovarian Cancer , Skin Squamous Cell Carcinoma , Preclinical Introduction , Initial Public Offering , American Association , Cancer Research , Annual Oppenheimer Healthcare Conference ,

ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference


ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference
News provided by
Share this article
Share this article
CLEVELAND, March 5, 2021 /PRNewswire/  ViewRay, Inc. (NASDAQ: VRAY) (the Company ) today announced that members of management will be participating in the 21
st Annual Oppenheimer Healthcare Conference on Tuesday, March 16, 2021.  ViewRay will be conducting a virtual fireside chat at 3:50 PM ET, as well as hosting 1x1 meetings with investors.
A live webcast of the Company s fireside chat will be available on the Financial Events and Webinars section of ViewRay s investor website at:  https://investors.viewray.com/events-and-presentations/upcoming-events. A replay of the presentation will be available for the following 7 days. ....

Viewray Inc , Annual Oppenheimer Healthcare Conference , ஆண்டு ஆபெந்ஹைமர் சுகாதாரம் மாநாடு ,